Expression of certain biomarkers such as Hormone Receptors (HR) which includes estrogen receptor (ER), progesterone receptor (PR) and Human Epithelial growth factor Receptor 2 (HER2) can further classify breast cancer into molecular subtypes (Figure 1). This evidence concerns the gene ERBB2 and breast cancer.